An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.

Tau protein is a key target of interest in developing therapeutics for neurodegenerative diseases. Here, we sought to develop a method that quantifies extracellular tau protein concentrations in human cerebrospinal fluid (CSF) without antibody-based enrichment strategies. We demonstrate that the fit...

Full description

Bibliographic Details
Main Authors: Wade Self, Khader Awwad, John Paul Savaryn, Michael Schulz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0269157
_version_ 1811289744026370048
author Wade Self
Khader Awwad
John Paul Savaryn
Michael Schulz
author_facet Wade Self
Khader Awwad
John Paul Savaryn
Michael Schulz
author_sort Wade Self
collection DOAJ
description Tau protein is a key target of interest in developing therapeutics for neurodegenerative diseases. Here, we sought to develop a method that quantifies extracellular tau protein concentrations in human cerebrospinal fluid (CSF) without antibody-based enrichment strategies. We demonstrate that the fit-for-purpose validated method in Alzheimer's Disease CSF is limited to quasi quantitative measures of tau surrogate peptides. We also provide evidence that CSF total Tau measures by LC-MS are feasible in the presence of monoclonal therapeutic antibodies in human CSF. Our Tau LC-MS/MS method is a translational bioanalytical tool for assaying target engagement and pharmacodynamics for anti-tau antibody drug development campaigns.
first_indexed 2024-04-13T04:00:54Z
format Article
id doaj.art-50a4e3e212e143dd8ace87036d009ac9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T04:00:54Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-50a4e3e212e143dd8ace87036d009ac92022-12-22T03:03:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01176e026915710.1371/journal.pone.0269157An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.Wade SelfKhader AwwadJohn Paul SavarynMichael SchulzTau protein is a key target of interest in developing therapeutics for neurodegenerative diseases. Here, we sought to develop a method that quantifies extracellular tau protein concentrations in human cerebrospinal fluid (CSF) without antibody-based enrichment strategies. We demonstrate that the fit-for-purpose validated method in Alzheimer's Disease CSF is limited to quasi quantitative measures of tau surrogate peptides. We also provide evidence that CSF total Tau measures by LC-MS are feasible in the presence of monoclonal therapeutic antibodies in human CSF. Our Tau LC-MS/MS method is a translational bioanalytical tool for assaying target engagement and pharmacodynamics for anti-tau antibody drug development campaigns.https://doi.org/10.1371/journal.pone.0269157
spellingShingle Wade Self
Khader Awwad
John Paul Savaryn
Michael Schulz
An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
PLoS ONE
title An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
title_full An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
title_fullStr An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
title_full_unstemmed An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
title_short An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
title_sort immuno enrichment free validated quantification of tau protein in human csf by lc ms ms
url https://doi.org/10.1371/journal.pone.0269157
work_keys_str_mv AT wadeself animmunoenrichmentfreevalidatedquantificationoftauproteininhumancsfbylcmsms
AT khaderawwad animmunoenrichmentfreevalidatedquantificationoftauproteininhumancsfbylcmsms
AT johnpaulsavaryn animmunoenrichmentfreevalidatedquantificationoftauproteininhumancsfbylcmsms
AT michaelschulz animmunoenrichmentfreevalidatedquantificationoftauproteininhumancsfbylcmsms
AT wadeself immunoenrichmentfreevalidatedquantificationoftauproteininhumancsfbylcmsms
AT khaderawwad immunoenrichmentfreevalidatedquantificationoftauproteininhumancsfbylcmsms
AT johnpaulsavaryn immunoenrichmentfreevalidatedquantificationoftauproteininhumancsfbylcmsms
AT michaelschulz immunoenrichmentfreevalidatedquantificationoftauproteininhumancsfbylcmsms